Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pichler

Showing results (11-20 of 323) with videos related to

Pageof 33
Sort By:
Molecular Oncology|November 16, 2018
Involvement of the long noncoding RNA NEAT1 in carcinogenesisChristiane Klec, Felix Prinz, Martin Pichler
Anticancer Research|June 13, 2014
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapyAngelika Bezan, Armin Gerger, Martin Pichler
Trends in Pharmacological Sciences|May 11, 2024
Enhancing oncogenic signaling to kill cancer cellsMaxim Noeparast, Oleg Timofeev, Martin Pichler
Molecular and Clinical Oncology|March 21, 2014
Epigenetic control of epithelial-mesenchymal-transition in human cancerTobias Kiesslich, Martin Pichler, Daniel Neureiter
Expert Opinion on Therapeutic Targets|October 27, 2018
Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancerJohannes Foßelteder, George A Calin, Martin Pichler
Advances in Experimental Medicine and Biology|December 15, 2015
microRNAs and Colorectal CancerAnna Lena Ress, Samantha Perakis, Martin Pichler
Annals of Translational Medicine|February 24, 2015
Multi-omics in prognosis of hepatocellular carcinomaAnna Lena Ress, Rishi Wagle, Martin Pichler
International Journal of Molecular Sciences|April 29, 2020
RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in CancerKatharina Jonas, George A Calin, Martin Pichler
Future Oncology (London, England)|January 17, 2015
RNA interference in the clinics: where are we standing now?Rishi Wagle, Masahisa Ohtsuka, Hui Ling, et al.
International Journal of Molecular Sciences|February 6, 2019
The Implications of the Long Non-Coding RNA <i>NEAT1</i> in Non-Cancerous DiseasesFelix Prinz, Anita Kapeller, Martin Pichler, et al.
Pageof 33

Showing results (11-20 of 323) with videos related to

Sort By:
Pageof 33
Molecular Oncology|November 16, 2018
Involvement of the long noncoding RNA NEAT1 in carcinogenesisChristiane Klec, Felix Prinz, Martin Pichler
Anticancer Research|June 13, 2014
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapyAngelika Bezan, Armin Gerger, Martin Pichler
Trends in Pharmacological Sciences|May 11, 2024
Enhancing oncogenic signaling to kill cancer cellsMaxim Noeparast, Oleg Timofeev, Martin Pichler
Molecular and Clinical Oncology|March 21, 2014
Epigenetic control of epithelial-mesenchymal-transition in human cancerTobias Kiesslich, Martin Pichler, Daniel Neureiter
Expert Opinion on Therapeutic Targets|October 27, 2018
Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancerJohannes Foßelteder, George A Calin, Martin Pichler
Advances in Experimental Medicine and Biology|December 15, 2015
microRNAs and Colorectal CancerAnna Lena Ress, Samantha Perakis, Martin Pichler
Annals of Translational Medicine|February 24, 2015
Multi-omics in prognosis of hepatocellular carcinomaAnna Lena Ress, Rishi Wagle, Martin Pichler
International Journal of Molecular Sciences|April 29, 2020
RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in CancerKatharina Jonas, George A Calin, Martin Pichler
Future Oncology (London, England)|January 17, 2015
RNA interference in the clinics: where are we standing now?Rishi Wagle, Masahisa Ohtsuka, Hui Ling, et al.
International Journal of Molecular Sciences|February 6, 2019
The Implications of the Long Non-Coding RNA <i>NEAT1</i> in Non-Cancerous DiseasesFelix Prinz, Anita Kapeller, Martin Pichler, et al.
Pageof 33